Joshua S. Lichtman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Joshua S. Lichtman has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Joshua E. Elias
Chan Zuckerberg Biohub, San Francisco, USA
3 shared publications - Alex DePaoli
NGM Biopharmaceuticals, South San Francisco, CA 94080, USA
1 shared publication - Andrew Hendifar
Cedars-Sinai Medical Center, Los Angeles, CA 90211, USA
1 shared publication Angela Marcobal
§Department of Microbiology and Immunology, Stanford University, Stanford, California
1 shared publication- Benjamin Adam Weinberg
Department of Oncology, Georgetown University Medical Center, Washington, DC 20007, USA
1 shared publication - Bevan Emma Huang
CSIRO Computational Informatics and Food Futures National Research Flagship
1 shared publication
Latest Publications
- 1 September 2021
- Published by Elsevier in Annals of Oncology
- Vol. 32, S610-S611
550P Initial results of a phase Ia/Ib study of NGM120, a first-in-class anti-GDNF family receptor alpha like (GFRAL) antibody in patients (pts) with advanced solid tumors
- 1 September 2021
- Published by Elsevier in Annals of Oncology
- Vol. 32, S610-S611
550P Initial results of a phase Ia/Ib study of NGM120, a first-in-class anti-GDNF family receptor alpha like (GFRAL) antibody in patients (pts) with advanced solid tumors
- 17 November 2015
- Published by Oxford University Press (OUP) in The ISME Journal
- Vol. 10 (5) , 1170-1181
The effect of microbial colonization on the host proteome varies by gastrointestinal location
Endogenous intestinal microbiota have wide-ranging and largely uncharacterized effects on host physiology. Here, we used reverse-phase liquid chromatography-coupled tandem mass spectrometry to define the mouse intestinal proteome in the stomach, jejunum, ileum, cecum and proximal colon under three colonization states: germ-free (GF), monocolonized with Bacteroides thetaiotaomicron and conventionally raised (CR). Our analysis revealed distinct proteomic abundance profiles along the gastrointestinal (GI) tract. Unsupervised clustering showed that host protein abundance primarily depended on GI location rather than colonization state and specific proteins and functions that defined these locations were identified by random forest classifications. K-means clustering of protein abundance across locations revealed substantial differences in host protein production between CR mice relative to GF and monocolonized mice. Finally, comparison with fecal proteomic data sets suggested that the identities of stool proteins are not biased to any region of the GI tract, but are substantially impacted by the microbiota in the distal colon.
- 17 November 2015
- Published by Oxford University Press (OUP) in The ISME Journal
- Vol. 10 (5) , 1170-1181
The effect of microbial colonization on the host proteome varies by gastrointestinal location
Endogenous intestinal microbiota have wide-ranging and largely uncharacterized effects on host physiology. Here, we used reverse-phase liquid chromatography-coupled tandem mass spectrometry to define the mouse intestinal proteome in the stomach, jejunum, ileum, cecum and proximal colon under three colonization states: germ-free (GF), monocolonized with Bacteroides thetaiotaomicron and conventionally raised (CR). Our analysis revealed distinct proteomic abundance profiles along the gastrointestinal (GI) tract. Unsupervised clustering showed that host protein abundance primarily depended on GI location rather than colonization state and specific proteins and functions that defined these locations were identified by random forest classifications. K-means clustering of protein abundance across locations revealed substantial differences in host protein production between CR mice relative to GF and monocolonized mice. Finally, comparison with fecal proteomic data sets suggested that the identities of stool proteins are not biased to any region of the GI tract, but are substantially impacted by the microbiota in the distal colon.
- 9 June 2015
- Published by Oxford University Press (OUP) in The ISME Journal
- Vol. 9 (9) , 1908-1915
Monitoring host responses to the gut microbiota
The gastrointestinal (GI) ecosystem is increasingly understood to be a fundamental component of health, and has been identified as a new focal point for diagnosing, correcting and preventing countless disorders. Shotgun DNA sequencing has emerged as the dominant technology for determining the genetic and microbial composition of the gut microbiota. This technology has linked microbiota dysbioses to numerous GI diseases including inflammatory bowel disease, obesity and allergy, and to non-GI diseases like autism and depression. The importance of establishing causality in the deterioration of the host–microbiota relationship is well appreciated; however, discovery of candidate molecules and pathways that underlie mechanisms remains a major challenge. Targeted approaches, transcriptional assays, cytokine panels and imaging analyses, applied to animals, have yielded important insight into host responses to the microbiota. However, non-invasive, hypothesis-independent means of measuring host responses in humans are necessary to keep pace with similarly unbiased sequencing efforts that monitor microbes. Mass spectrometry-based proteomics has served this purpose in many other fields, but stool proteins exist in such diversity and dynamic range as to overwhelm conventional proteomics technologies. Focused analysis of host protein secretion into the gut lumen and monitoring proteome-level dynamics in stool provides a tractable route toward non-invasively evaluating dietary, microbial, surgical or pharmacological intervention efficacies. This review is intended to guide GI biologists and clinicians through the methods currently used to elucidate host responses in the gut, with a specific focus on mass spectrometry-based shotgun proteomics applied to the study of host protein dynamics within the GI ecosystem.
- 9 June 2015
- Published by Oxford University Press (OUP) in The ISME Journal
- Vol. 9 (9) , 1908-1915
Monitoring host responses to the gut microbiota
The gastrointestinal (GI) ecosystem is increasingly understood to be a fundamental component of health, and has been identified as a new focal point for diagnosing, correcting and preventing countless disorders. Shotgun DNA sequencing has emerged as the dominant technology for determining the genetic and microbial composition of the gut microbiota. This technology has linked microbiota dysbioses to numerous GI diseases including inflammatory bowel disease, obesity and allergy, and to non-GI diseases like autism and depression. The importance of establishing causality in the deterioration of the host–microbiota relationship is well appreciated; however, discovery of candidate molecules and pathways that underlie mechanisms remains a major challenge. Targeted approaches, transcriptional assays, cytokine panels and imaging analyses, applied to animals, have yielded important insight into host responses to the microbiota. However, non-invasive, hypothesis-independent means of measuring host responses in humans are necessary to keep pace with similarly unbiased sequencing efforts that monitor microbes. Mass spectrometry-based proteomics has served this purpose in many other fields, but stool proteins exist in such diversity and dynamic range as to overwhelm conventional proteomics technologies. Focused analysis of host protein secretion into the gut lumen and monitoring proteome-level dynamics in stool provides a tractable route toward non-invasively evaluating dietary, microbial, surgical or pharmacological intervention efficacies. This review is intended to guide GI biologists and clinicians through the methods currently used to elucidate host responses in the gut, with a specific focus on mass spectrometry-based shotgun proteomics applied to the study of host protein dynamics within the GI ecosystem.
- Open Access
- 20 October 2014
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 111 (44) , 15780-15785
Role of disease-associated tolerance in infectious superspreaders
Significance: A minority of infected hosts is thought to be responsible for the majority of pathogen transmission events. Surprisingly little is known about what distinguishes superspreader hosts from the rest of the infected population. Using a mouse model of Salmonella infection, we show that levels of Salmonella are equivalent between antibiotic-treated superspreader and nonsuperspreader hosts; however, superspreader hosts are uniquely able to tolerate antibiotic treatment, unlike nonsuperspreader hosts. We find that nonsuperspreaders have a hyperinflammatory response to antibiotic treatment, resulting in increased inflammatory myeloid cells that contribute to the morbidity observed. Superspreaders display neither an increased frequency of inflammatory myeloid cells nor morbidity upon antibiotic treatment. Our data describe tolerance mechanisms unique to superspreader hosts that enable sustained pathogen transmission.
- 20 October 2014
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 111 (44) , 15780-15785
Open AccessRole of disease-associated tolerance in infectious superspreaders
Significance: A minority of infected hosts is thought to be responsible for the majority of pathogen transmission events. Surprisingly little is known about what distinguishes superspreader hosts from the rest of the infected population. Using a mouse model of Salmonella infection, we show that levels of Salmonella are equivalent between antibiotic-treated superspreader and nonsuperspreader hosts; however, superspreader hosts are uniquely able to tolerate antibiotic treatment, unlike nonsuperspreader hosts. We find that nonsuperspreaders have a hyperinflammatory response to antibiotic treatment, resulting in increased inflammatory myeloid cells that contribute to the morbidity observed. Superspreaders display neither an increased frequency of inflammatory myeloid cells nor morbidity upon antibiotic treatment. Our data describe tolerance mechanisms unique to superspreader hosts that enable sustained pathogen transmission.
- Open Access
- 1 November 2013
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 12 (11) , 3310-3318
Host-centric Proteomics of Stool: A Novel Strategy Focused on intestinal Responses to the Gut Microbiota
- 1 November 2013
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 12 (11) , 3310-3318
Open AccessHost-centric Proteomics of Stool: A Novel Strategy Focused on intestinal Responses to the Gut Microbiota